The Use of Implantable Cardioverter-defibrillators in the Prevention of Sudden Cardiac Death: A Focus on Congenital Heart Disease and Inherited Arrhythmia Syndromes.

Journal Article (Journal Article;Review)

Some congenital heart diseases (CHDs) and inherited arrhythmia syndromes are associated with an increased risk of sudden cardiac death (SCD). Appropriate selection criteria for implantable cardioverter-defibrillator (ICD) implantation in these patients are poorly defined due to a paucity of data available from randomized clinical trials, leading to current guidelines relying more on non-randomized studies and expert opinions to make their recommendations. This review describes available evidence-based risk stratification methods for identifying patients at risk for SCD, as well as current guideline-driven management strategies for the use of ICDs in patients with CHD and inherited arrhythmia syndromes.

Full Text

Duke Authors

Cited Authors

  • Goldstein, SA; Ward, CC; Al-Khatib, SM

Published Date

  • January 2018

Published In

Volume / Issue

  • 9 / 1

Start / End Page

  • 2996 - 3005

PubMed ID

  • 32494470

Pubmed Central ID

  • PMC7252881

International Standard Serial Number (ISSN)

  • 2156-3977

Digital Object Identifier (DOI)

  • 10.19102/icrm.2018.090103


  • eng

Conference Location

  • United States